Popular anti-diabetic drug may reduce cancer risk: New study informs

A team of researchers from Denmark, A popular anti-diabetic drug (anti-diabetic medicine) It has also been found to reduce the risk of blood cancer.

People Metformin When using the drug, It is a myeloproliferative neoplasmSy (MPN- myeloproliferative neoplasms) Significantly reduces the risk of developing.

MPN The bone marrow contains too many red blood cells, A disorder that makes too few white blood cells or platelets.

Typ 2 Metformin for diabetes, Effectively lowers blood glucose levels by reducing glucose production in the liver. It reduces intestinal absorption and increases insulin sensitivity.

How long have people been using metformin?, To that extent MPNs A team of scientists found that the risk of developing is reduced. The findings of the study were published in the American Society of Hematology Blood Advanced Published in the magazine.

Compared to those who took less than a year of treatment, We found a stronger effect in people who had been taking metformin for more than five yearsthat Daniel D., a researcher at Aalborg University Hospital in Denmark and lead author of the study. Christensen, He said.

MPN Chronic myelogenous leukemia, Red blood cells, Platelets or eosinophils, Notably, many rare cancers involve certain types of white blood cells called neutrophils.

This Disorders Anemia, Infections, Bleeding problems and fatigue may accompany other symptoms.

MPN Although the research team was unable to assess exactly why metformin protected against the development, The researchers stress that more research will be conducted to better understand why.

The researchers aim to identify similar trends with myelodysplastic syndromes and acute myeloid leukemia in population-level data for future study., The study said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here